Get the Stockscreener App
25.94
8.85%
-2.52
After Hours:
25.94
Vera Therapeutics Inc stock is traded at $25.94, with a volume of 2.12M.
It is down -8.85% in the last 24 hours and down -13.93% over the past month.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
See More
Previous Close:
$28.46
Open:
$28.09
24h Volume:
2.12M
Relative Volume:
1.38
Market Cap:
$1.66B
Revenue:
-
Net Income/Loss:
$-218.28M
P/E Ratio:
-7.2452
EPS:
-3.5803
Net Cash Flow:
$-186.55M
1W Performance:
-14.70%
1M Performance:
-13.93%
6M Performance:
+2.49%
1Y Performance:
-40.80%
1-Day Range:
$25.10
$28.67
1-Week Range:
$25.10
$30.46
52-Week Range:
$18.53
$51.61
Vera Therapeutics Inc Stock (VERA) Company Profile
Name
Vera Therapeutics Inc
Sector
Industry
Phone
650-770-0077
Address
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Compare VERA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
25.94 | 1.82B | 0 | -218.28M | -186.55M | -3.5803 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-16-25 | Initiated | BofA Securities | Buy |
| Aug-04-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| May-05-25 | Resumed | H.C. Wainwright | Buy |
| Feb-04-25 | Initiated | Wolfe Research | Outperform |
| Jan-28-25 | Initiated | Goldman | Buy |
| Nov-21-24 | Initiated | Wells Fargo | Overweight |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Jan-25-24 | Initiated | Oppenheimer | Outperform |
| Jan-08-24 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-18-23 | Initiated | Raymond James | Outperform |
| Nov-10-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-16-23 | Initiated | Guggenheim | Buy |
| Jan-04-23 | Downgrade | Jefferies | Buy → Hold |
| Jan-04-23 | Downgrade | Wedbush | Outperform → Neutral |
| Jul-12-22 | Initiated | JP Morgan | Overweight |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-19-22 | Initiated | Wedbush | Outperform |
View All
Vera Therapeutics Inc Stock (VERA) Latest News
Building trade automation scripts for Vera Therapeutics Inc.Weekly Profit Analysis & Verified Swing Trading Watchlists - newser.com
Is Vera Therapeutics Inc. still worth holding after the dipMarket Activity Recap & Community Verified Watchlist Alerts - newser.com
Can Vera Therapeutics Inc. stock maintain operating marginsJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com
How high can Vera Therapeutics Inc. stock goJuly 2025 PreEarnings & Fast Entry High Yield Tips - newser.com
Vera Therapeutics Inc. stock chart pattern explainedWeekly Stock Analysis & Weekly Chart Analysis and Trade Guides - newser.com
What MACD signals say about Vera Therapeutics Inc.July 2025 Analyst Calls & Precise Buy Zone Tips - newser.com
Historical volatility pattern of Vera Therapeutics Inc. visualizedEarnings Miss & Advanced Technical Signal Analysis - newser.com
How Vera Therapeutics Inc. stock benefits from strong dollar2025 Market Outlook & Real-Time Market Trend Scan - newser.com
Ranking Vera Therapeutics Inc. among high performing stocks via toolsMarket Growth Report & Low Volatility Stock Recommendations - newser.com
Can Vera Therapeutics Inc. hit a new high this monthQuarterly Trade Review & Consistent Income Trade Ideas - newser.com
Applying sector rotation models to Vera Therapeutics Inc.Market Volume Report & Technical Entry and Exit Tips - newser.com
Pivotal Week Ahead for Vera Therapeutics Investors - AD HOC NEWS
Applying Wyckoff theory to Vera Therapeutics Inc. stockJuly 2025 Recap & Safe Capital Growth Stock Tips - newser.com
How to build a custom watchlist for Vera Therapeutics Inc.Weekly Stock Recap & Weekly Stock Performance Updates - newser.com
How Vera Therapeutics’ (VERA) Phase 3 IgA Nephropathy Data Spotlight May Influence Investor Sentiment - Sahm
Vera Therapeutics (VERA) to Release Earnings on Thursday - MarketBeat
How to interpret RSI for Vera Therapeutics Inc. stockJuly 2025 EndofMonth & High Conviction Buy Zone Picks - newser.com
Will Vera Therapeutics Inc. stock continue dividend increasesWeekly Risk Report & Verified Entry Point Signals - newser.com
Is Vera Therapeutics Inc. stock a buy before product launchesSell Signal & Reliable Entry Point Alerts - fcp.pa.gov.br
Vera Therapeutics Inc Stock (VERA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Vera Therapeutics Inc Stock (VERA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ENRIGHT PATRICK G | Director |
Jun 24 '25 |
Buy |
22.35 |
40,607 |
907,635 |
3,596,593 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 21 '25 |
Sale |
27.89 |
10,613 |
296,032 |
213,740 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 26 '25 |
Sale |
27.65 |
9,075 |
250,882 |
204,665 |
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):